Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk
Launched by UNIVERSITY OF COLORADO, DENVER · Oct 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people recover from mild concussions, also known as mild traumatic brain injuries (TBIs). Researchers want to see if using a smartphone app for assessments and virtual exercises can effectively support recovery and reduce the chance of future injuries. The study is open to healthy U.S. military members and active young adults aged 18 to 40 who have recently been diagnosed with a concussion.
To participate, individuals need to meet certain criteria, such as having a mild concussion confirmed by a doctor and being physically active before their injury. Participants should have access to a smartphone since the program will be delivered through an app. If you join this study, you can expect to engage in virtual exercises designed to help improve your balance and coordination. This innovative approach aims to make recovery easier and more accessible for those who need it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-40 years of age at the time of enrollment
- • Mild TBI or concussion diagnosis by a physician
- • Confirmed MTBI diagnosis via VA/DOD guidelines at time of enrollment
- • Participation in regular physical activity prior to injury (confirmed via the Global Physical Activity Questionnaire \[GPAQ\]) (Cleland et al., 2014; Keating et al., 2019)
- • Access to a smartphone for app download
- Exclusion Criteria:
- • Moderate or severe TBI
- • Pre-injury neurological disorder
- • Abnormal brain imaging findings (if performed as a part of routine care)
- • Previous TBI (mild/moderate/severe) \<12 months prior to enrollment other than the current injury for which they are being seen
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Fort Sam Houston, Texas, United States
Patients applied
Trial Officials
David R Howell, PhD
Principal Investigator
University of Colorado School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials